Tema Cardiovascular and Metabolic ETF (HRTS)
NASDAQ: HRTS · IEX Real-Time Price · USD
30.61
-0.18 (-0.58%)
Dec 29, 2023, 4:00 PM EST - Market closed
-0.58% (1D)
| Assets | $16.77M |
| Expense Ratio | 0.75% |
| PE Ratio | n/a |
| Shares Out | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | 6,710 |
| Open | 30.99 |
| Previous Close | 30.79 |
| Day's Range | 30.61 - 30.99 |
| 52-Week Low | 26.26 |
| 52-Week High | 33.56 |
| Beta | n/a |
| Holdings | n/a |
| Inception Date | Nov 20, 2023 |
About HRTS
Fund Home PageThe Tema Cardiovascular and Metabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.
Asset Class Equity
Stock Exchange NASDAQ
Ticker Symbol HRTS
ETF Provider Tema
News
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund
Tema ETFs has launched a new exchange traded fund (ETF) that tracks popular drugmakers like Novo Nordisk and Eli Lilly , aiming to tap into growing demand for their weight-loss and diabetes drugs.
5 weeks ago - Reuters